{
    "2020-11-02": [
        [
            {
                "time": "2018-10-24",
                "original_text": "Illumina (ILMN) Q3 Earnings Top Estimates, Margins Decline",
                "features": {
                    "keywords": [
                        "Illumina",
                        "Q3",
                        "Earnings",
                        "Top",
                        "Estimates",
                        "Margins",
                        "Decline"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "NuVasive (NUVA) Q3 Earnings Beat, Gross Margin Declines",
                "features": {
                    "keywords": [
                        "NuVasive",
                        "Q3",
                        "Earnings",
                        "Beat",
                        "Gross",
                        "Margin",
                        "Declines"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Rise",
                "features": {
                    "keywords": [
                        "ResMed",
                        "Q1",
                        "Earnings",
                        "Surpass",
                        "Estimates",
                        "Margins",
                        "Rise"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-27",
                "original_text": "Exact Sciences (EXAS) Loses 5.6% Despite Beating Q3 Earnings",
                "features": {
                    "keywords": [
                        "Exact",
                        "Sciences",
                        "Loses",
                        "5.6%",
                        "Despite",
                        "Beating",
                        "Q3",
                        "Earnings"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "diagnostics"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-28",
                "original_text": "Henry Schein (HSIC) Q3 Earnings Top Estimates, Margins Dip",
                "features": {
                    "keywords": [
                        "Henry",
                        "Schein",
                        "Q3",
                        "Earnings",
                        "Top",
                        "Estimates",
                        "Margins",
                        "Dip"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "dental products"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-29",
                "original_text": "OPKO Health (OPK) Loses 16.2% Despite In-Line Q3 Earnings",
                "features": {
                    "keywords": [
                        "OPKO",
                        "Health",
                        "Loses",
                        "16.2%",
                        "Despite",
                        "In-Line",
                        "Q3",
                        "Earnings"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "diagnostics"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Allscripts (MDRX) Declines 1.9% Despite Q3 Earnings Beat",
                "features": {
                    "keywords": [
                        "Allscripts",
                        "Declines",
                        "1.9%",
                        "Despite",
                        "Q3",
                        "Earnings",
                        "Beat"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "IT services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}